Tolcapone

Routes
Oral (PO)
Half-Life (t½)
PO: 1.8h
Formula
C14H11NO5
Molecular Weight
273.24 g/mol
PubChem CID
4659569
Aliases
Tasmar, Ro 40-7592

Pharmacological Mechanism

Reversible nitrocatechol inhibitor of catechol-O-methyltransferase (COMT), acting both peripherally and — unlike entacapone — within the CNS, which is why it is the COMT inhibitor used as a probe in prefrontal-dopamine and COMT Val158Met cognition research as well as a levodopa adjunct in Parkinson's disease. Erythrocyte COMT is inhibited by more than 80% at single oral doses of 200 mg and above. Carries a boxed warning for fulminant hepatic failure, so it is used with liver-enzyme monitoring.

Half-Life & Elimination Curve (PO: 1.8h)

100%50%25%12.5%0%0h0×t½1.8h1×t½3.6h2×t½5.4h3×t½7.2h4×t½9h5×t½0×t½ (0h): 100% remaining1×t½ (1.8h): 50% remaining2×t½ (3.6h): 25% remaining3×t½ (5.4h): 12.5% remaining4×t½ (7.2h): 6.3% remaining5×t½ (9h): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½1.8h50%
  • 2×t½3.6h25%
  • 3×t½5.4h12.5%
  • 4×t½7.2h6.3%
  • 5×t½9h3.1%
Elimination t½1.8h (PO)
Rate Constant (ke)0.385 h⁻¹
97% Washout (5×t½)9h

Dosing Guidelines

Pharmacokinetic Parameters

Target Organ Systems

Notes

PubChem CID 4659569 (C14H11NO5). PK: Jorga 1998 (PMID:9754991), sixteen healthy male volunteers, 200 mg oral vs 50 mg intravenous crossover — an ABSOLUTE bioavailability study. Verbatim: "The absolute bioavailability of an oral dose was approximately 60%", "resulting in a mean plasma half-life of 1.8 h", and "After an initial lag time of 0.5 h, tolcapone was rapidly absorbed". All three are stored. t½ cross-checks against the independent first-in-human study PMID:7768073: "Its mean elimination half-life was 2.0 +/- 0.8 hours (n = 42)". VOLUME AND CLEARANCE NOT STORED BECAUSE THEY ARE NOT READABLE: PubMed's indexed record of this abstract renders them as "the volume of distribution was approximately 9 1, and the total clearance was approximately 71.h-l" — OCR damage, present in the XML as well as the text rendering, and the three quantities as transcribed do not close (9 L at t½ 1.8 h implies 3.5 L/h, not 7). Guessing the intended units to recover a number would be transcription dressed as authoring. Logged in AUTHORING_GAPS.md; a full-text page-1 read unlocks both, and V would matter here because 35 L is the default that a 9 L central volume is nowhere near. ka NOT STORED either: the abstract says peaks were reached "within approximately 2 h" and that absorption followed "either zero- or first-order" kinetics, which is a bound and a hedge rather than a stated Tmax. PD: PMID:7768073 verbatim "At doses of 200 mg and higher, COMT activity was inhibited by more than 80%" — informational; no Hill row authored, since erythrocyte enzyme inhibition is not receptor occupancy. Dose range is the marketed 100 mg and 200 mg three-times-daily strengths; the cited studies used single 200 mg (PMID:9754991) and ascending 5-800 mg (PMID:7768073) doses.

Chemical Structure & Identifiers

References